Sign In
Buy MGTA
$0.700
+0 (+0%)
At Close: Dec 08, 2023
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA
07:04pm, Tuesday, 16'th Jun 2020SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA
07:03pm, Tuesday, 16'th Jun 2020
Pomerantz LLP is investigating claims on behalf of investors of Magenta Therapeutics, Inc. (“Magenta” or the “Company”) (NASDAQ: MGTA). Such investors are advised to contact Robert S. Will
Biogen's NURTURE Data, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:BIIB)
08:55am, Tuesday, 16'th Jun 2020
Biogen reports positive data from the NURTURE study. Magenta quits inherited metabolic disorder study. Clovis completes enrolment in RUBRACA study.
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Magenta Therapeutics, Inc. ("Magenta" or the "Company") (NASDAQ: MGTA). Investor
Magenta Therapeutics (Nasdaq: MGTA) and Beam Therapeutics (Nasdaq: BEAM) today announced a non-exclusive research and clinical collaboration agreement to evaluate the potential utility of MGTA-117, Ma
Analysts Are Bullish on These Healthcare Stocks: Magenta Therapeutics (MGTA), Viela Bio (VIE) - Markets
01:55am, Monday, 15'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Magenta Therapeutics
Magenta Therapeutics (Nasdaq: MGTA) and Beam Therapeutics (Nasdaq: BEAM) today announced a non-exclusive research and clinical collaboration agreement
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA
01:09pm, Saturday, 13'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 13, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Magenta Therapeutics, Inc. ("Magenta" or the "Company") (NASDAQ:MGTA). Such ...
NEW YORK, NY / ACCESSWIRE / June 12, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Magenta Therapeutics, Inc. ("Magenta" or the "Company") ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA
07:09pm, Thursday, 11'th Jun 2020
Pomerantz LLP is investigating claims on behalf of investors of Magenta Therapeutics, Inc. (“Magenta” or the “Company”) (NASDAQ: MGTA). Such investors are advised to contact Robert S. Will
Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to...
Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today provided a portfolio
Magenta Therapeutics (Nasdaq: MGTA) and the National Marrow Donor Program® (NMDP)/Be The Match®, the global leader in providing a cure to patients with life-threatening blood and marrow cancers like
Magenta Therapeutics' Shares March Higher, Can It Continue?
10:47am, Thursday, 11'th Jun 2020
As of late, it has definitely been a great time to be an investor in Magenta Therapeutics.
New milestone for Hrvatski Telekom
09:14am, Thursday, 11'th Jun 2020
The converged telecom service Magenta 1 operated by the Croatian incumbent Hrvatski Telekom (HT) is now received in more than 250,000 households.
